Showing 13,081 - 13,100 results of 21,342 for search '(( significant decrease decrease ) OR ( significantly ((teer decrease) OR (greater decrease)) ))', query time: 0.50s Refine Results
  1. 13081

    Data Sheet 4_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …”
  2. 13082

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  3. 13083

    Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  4. 13084

    Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  5. 13085

    Comparison of the trend of people’s perceptions and the climatic trends (social data: Quantitative data: Household survey (n = 660); qualitative data: Focus group discussions (n =... by Parbati Phuyal (8687400)

    Published 2025
    “…Depending on the perception, the presence of a trend (yes, no, unclear/mixed) or a trend direction (increase, decrease, unclear) is given. Significance of each data type is presented in detail in Figs <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317786#pone.0317786.g002" target="_blank">2</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317786#pone.0317786.g005" target="_blank">5</a>. …”
  6. 13086

    <i>MMP-1</i> OE restores <i>5HT</i><sub><i>2A</i></sub><i>R</i>-deficient experience-dependent pruning. by Vanessa Kay Miller (19775496)

    Published 2025
    “…<i>MMP-1</i> OE restores synaptic pruning with a significant decrease of innervation volume in response to the EB odorant experience (blue, <i>n</i> = 10/condition, <i>p</i>-value = 4.43 × 10<sup>−13</sup>), which is nearly identical to the control. …”
  7. 13087

    Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  8. 13088

    Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  9. 13089

    Data Sheet 5_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Microbiome profiling was performed using 16S rRNA gene-targeted metagenomic sequencing, followed by comprehensive bioinformatics and statistical analyses.</p>Results<p>Significant differences were observed in both alpha and beta diversity measures, with alpha diversity decreasing as the severity of COVID-19 increased. …”
  10. 13090

    Data Sheet 2_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Microbiome profiling was performed using 16S rRNA gene-targeted metagenomic sequencing, followed by comprehensive bioinformatics and statistical analyses.</p>Results<p>Significant differences were observed in both alpha and beta diversity measures, with alpha diversity decreasing as the severity of COVID-19 increased. …”
  11. 13091

    Supplementary file 1_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.docx by Filippos S. Kardaras (18330696)

    Published 2025
    “…Microbiome profiling was performed using 16S rRNA gene-targeted metagenomic sequencing, followed by comprehensive bioinformatics and statistical analyses.</p>Results<p>Significant differences were observed in both alpha and beta diversity measures, with alpha diversity decreasing as the severity of COVID-19 increased. …”
  12. 13092

    Data Sheet 4_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Microbiome profiling was performed using 16S rRNA gene-targeted metagenomic sequencing, followed by comprehensive bioinformatics and statistical analyses.</p>Results<p>Significant differences were observed in both alpha and beta diversity measures, with alpha diversity decreasing as the severity of COVID-19 increased. …”
  13. 13093

    Data Sheet 1_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Microbiome profiling was performed using 16S rRNA gene-targeted metagenomic sequencing, followed by comprehensive bioinformatics and statistical analyses.</p>Results<p>Significant differences were observed in both alpha and beta diversity measures, with alpha diversity decreasing as the severity of COVID-19 increased. …”
  14. 13094

    Data Sheet 3_Identification of nasopharyngeal microbial dysbiosis in COVID-19 patients by 16S rRNA gene sequencing.xls by Filippos S. Kardaras (18330696)

    Published 2025
    “…Microbiome profiling was performed using 16S rRNA gene-targeted metagenomic sequencing, followed by comprehensive bioinformatics and statistical analyses.</p>Results<p>Significant differences were observed in both alpha and beta diversity measures, with alpha diversity decreasing as the severity of COVID-19 increased. …”
  15. 13095

    The effect of IFN-β and Vit D on the NF-κB gene expression. by Farzad Nasri (8941850)

    Published 2025
    “…Two lower concentrations of Vit D induced a reduction in the NF-κB expression compared to the control, while the highest concentration increased it significantly <b>(B)</b>. In the co-treatment groups, a dose-dependent decrease pattern among different concentration was seen in the NF-κB expression, but generally it was increased compared to the control <b>(C)</b>. …”
  16. 13096

    Example of a choice set for Best Worst Scaling. by Yachiyo Tobita (20613887)

    Published 2025
    “…<div><p>The COVID-19 pandemic triggered social and economic stagnation worldwide, significantly impacting people’s lives. In addition, the Russia-Ukraine war that began in 2022 resulted in rising food prices globally, severely affecting low- and middle-income countries. …”
  17. 13097

    Data Sheet 1_Utility of nonlinear analysis of heart rate variability in early detection of metabolic syndrome.docx by José Alberto Zamora-Justo (21590657)

    Published 2025
    “…Introduction<p>Metabolic syndrome (MetS) is a clinical condition characterized by multiple risk factors that significantly increase the likelihood of developing cardiovascular diseases and type 2 diabetes. …”
  18. 13098

    Table 2_Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study.xlsx by Margot Giocondo (21435500)

    Published 2025
    “…There was no significant change in T-score at the one-third radius. …”
  19. 13099

    Table 1_Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study.xlsx by Margot Giocondo (21435500)

    Published 2025
    “…There was no significant change in T-score at the one-third radius. …”
  20. 13100

    Table 1_The immediate pain relief of low-level laser therapy for burning mouth syndrome: a retrospective study of 94 cases.docx by Wenxin Mu (9911610)

    Published 2024
    “…</p>Results<p>After standardized LLLT session, 71.3% of patients reported an immediate pain decrease. Compared to pre-LLLT treatment, the VAS immediately post-LLLT was significantly reduced (P < 0.001). …”